Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,352,119
-
Share change
-
+587,916
-
Total reported value
-
$10,931,000
-
Price per share
-
$0.63
-
Number of holders
-
26
-
Value change
-
-$584,049
-
Number of buys
-
12
-
Number of sells
-
18
Institutional Holders of TRACON PHARMACEUTICALS INC - COM (TCON) as of Q4 2018
As of 31 Dec 2018,
TRACON PHARMACEUTICALS INC - COM (TCON) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,352,119 shares.
The largest 10 holders included
Puissance Capital Management LP, NEA Management Company, LLC, Linden Advisors LP, 683 Capital Management, LLC, Telemetry Investments, L.L.C., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, Anson Funds Management LP, BlackRock Inc., and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.